EA201992673A1 - TREATMENT OF INFLAMMATORY DISEASES USING C5a ACTIVITY INHIBITORS - Google Patents

TREATMENT OF INFLAMMATORY DISEASES USING C5a ACTIVITY INHIBITORS

Info

Publication number
EA201992673A1
EA201992673A1 EA201992673A EA201992673A EA201992673A1 EA 201992673 A1 EA201992673 A1 EA 201992673A1 EA 201992673 A EA201992673 A EA 201992673A EA 201992673 A EA201992673 A EA 201992673A EA 201992673 A1 EA201992673 A1 EA 201992673A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
inflammatory diseases
activity inhibitors
inhibitors
activity
Prior art date
Application number
EA201992673A
Other languages
Russian (ru)
Inventor
Ренфенг Гуо
Нильс Р Ридеманн
Original Assignee
Инфларкс Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Инфларкс Гмбх filed Critical Инфларкс Гмбх
Priority claimed from PCT/EP2018/065676 external-priority patent/WO2018234118A1/en
Publication of EA201992673A1 publication Critical patent/EA201992673A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к ингибиторам активности C5a и их применению при лечении кожных нейтрофильных воспалительных заболеваний у субъекта.The present invention relates to inhibitors of C5a activity and their use in the treatment of skin neutrophilic inflammatory diseases in a subject.

EA201992673A 2017-09-07 2018-06-13 TREATMENT OF INFLAMMATORY DISEASES USING C5a ACTIVITY INHIBITORS EA201992673A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17189938 2017-09-07
PCT/EP2018/065676 WO2018234118A1 (en) 2017-06-23 2018-06-13 Treatment of inflammatory diseases with inhibitors of c5a activity

Publications (1)

Publication Number Publication Date
EA201992673A1 true EA201992673A1 (en) 2020-05-20

Family

ID=59829243

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201992012A EA201992012A1 (en) 2017-09-07 2018-01-03 TREATMENT OF INFLAMMATORY DISEASES USING C5a ACTIVITY INHIBITORS
EA201992673A EA201992673A1 (en) 2017-09-07 2018-06-13 TREATMENT OF INFLAMMATORY DISEASES USING C5a ACTIVITY INHIBITORS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201992012A EA201992012A1 (en) 2017-09-07 2018-01-03 TREATMENT OF INFLAMMATORY DISEASES USING C5a ACTIVITY INHIBITORS

Country Status (1)

Country Link
EA (2) EA201992012A1 (en)

Also Published As

Publication number Publication date
EA201992012A1 (en) 2020-03-30

Similar Documents

Publication Publication Date Title
MX2019011825A (en) Treatment of inflammatory diseases with inhibitors of c5a activity.
CY1122344T1 (en) BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN THE THERAPEUTIC TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201790195A1 (en) METHODS OF TREATING CANCER WITH THE USE OF TIGIT INHIBITORS AND ANTI-CANCER AGENTS
EA201991214A1 (en) ANTIBODIES AGAINST PD-1 AND THEIR COMPOSITION
EA201790737A1 (en) COMBINED THERAPY
TWD196868S (en) Ultrasound therapeutic treatment handpiece
EA201691582A1 (en) NEW PHARMACEUTICAL PREPARATIONS
CR20220325A (en) Fluoroalkyl-oxadiazoles and uses thereof
EA202090031A3 (en) HUMAN ANTIBODIES AGAINST GFR3 AND METHODS OF THEIR USE
TWD196866S (en) Ultrasound therapeutic treatment console
EA201500816A1 (en) SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR APPLICATION AS NEUTROFIL ELASTASY ACTIVITY INHIBITORS
MX2023010501A (en) Dantrolene prodrugs and methods of their use.
IL271074A (en) Treatment of inflammatory diseases with inhibitors of c5a activity
MA46061A (en) ASCAROSIDE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
EA201792610A1 (en) METHOD OF TREATMENT OF NEUROLOGICAL DISEASE
TWD198498S (en) Ultrasound therapeutic treatment transducer
PH12017500217B1 (en) Anti-orai1 antibody
EA201892297A1 (en) METHODS FOR TREATING CHOLESTATIC AND FIBROTIC DISEASES
EA201790282A1 (en) SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR APPLICATION AS NEUTROFIL-ELASTASY ACTIVITY INHIBITORS
EA202090266A1 (en) MPO INHIBITORS FOR MEDICAL USE
TWD196867S (en) Ultrasound therapeutic treatment cart
EA201992389A1 (en) SUBSTITUTED N-ARILETHYL-2-AMINOCHINOLIN-4-CARBOXAMIDES AND THEIR APPLICATION
EA201992673A1 (en) TREATMENT OF INFLAMMATORY DISEASES USING C5a ACTIVITY INHIBITORS
EA201992386A1 (en) SUBSTITUTED N-ARILETHYL-2-ARILKHINOLIN-4-CARBOXAMIDES AND THEIR APPLICATION